Bacterial Cell with a Chemically Synthesized Genome

  • Thread starter Thread starter Gokul43201
  • Start date Start date
  • Tags Tags
    Cell
AI Thread Summary
Scientists have successfully created a bacterial cell controlled entirely by a synthetic genome, marking a significant milestone in synthetic biology. This synthetic cell, derived from a chemically synthesized chromosome, is capable of self-replication and offers potential applications in environmental and energy solutions. The project, led by Craig Venter, involved synthesizing a genome of 1.08 million base pairs and transplanting it into a host cell. The research aims to explore the fundamental mechanisms of life and the engineering of microorganisms for various applications. This breakthrough paves the way for future advancements in synthetic life and biotechnology.
Gokul43201
Staff Emeritus
Science Advisor
Gold Member
Messages
7,207
Reaction score
25
Scientists 'Boot Up' a Bacterial Cell With a Synthetic Genome

ScienceDaily (May 20, 2010) — Scientists have developed the first cell controlled by a synthetic genome. They now hope to use this method to probe the basic machinery of life and to engineer bacteria specially designed to solve environmental or energy problems.
...
"This is the first synthetic cell that's been made, and we call it synthetic because the cell is totally derived from a synthetic chromosome, made with four bottles of chemicals on a chemical synthesizer, starting with information in a computer," said Venter.

"This becomes a very powerful tool for trying to design what we want biology to do. We have a wide range of applications [in mind]," he said.

http://www.sciencedaily.com/releases/2010/05/100520131435.htm

Sounds really neat!

Reference: D. G. Gibson et al "Creation of a Bacterial Cell Controlled by a Chemically Synthesized Genome" Science, May 20, 2010 (DOI: 10.1126/science.1190719)

Link: http://www.sciencemag.org/cgi/content/abstract/science.1190719

Abstract:
We report the design, synthesis, and assembly of the 1.08-Mbp Mycoplasma mycoides JCVI-syn1.0 genome starting from digitized genome sequence information and its transplantation into a Mycoplasma capricolum recipient cell to create new Mycoplasma mycoides cells that are controlled only by the synthetic chromosome. The only DNA in the cells is the designed synthetic DNA sequence, including "watermark" sequences and other designed gene deletions and polymorphisms, and mutations acquired during the building process. The new cells have expected phenotypic properties and are capable of continuous self-replication.

See also: http://www.jcvi.org/cms/research/projects/first-self-replicating-synthetic-bacterial-cell/overview/
 
Biology news on Phys.org
Very exciting and neat indeed. It's not really surprising though, I knew it would come sooner or later.

For those that aren't quite sure how this is different from other genetic modifications basically it's the amount of genes modified. Genetic engineer 'changes' or manipulates a very small amount of genes relative to the amount of genes that are available in the organism. What they've done here is recoded basically the entire genome (actually I think it was the entire genome) of the organism such that it can self-replicate. This required something like 1 million basepairs... Quite a feat if you ask me :-p. I hope that this field continues to grow as it has been the last decade or so.
 
OMG OMG OMG OMG OMG OMG OMG *takes a deep breath*

OMG OMG OMG OMG OMG! *wipes away a tear*

This is truly amazing. I've been waiting to see this in the news for years now.
 
Craig Venter has been doing gene sequencing a long time.

This http://www.ted.com/talks/craig_venter_on_dna_and_the_sea.html" is a precursor of the announcement today.

This was filmed July 2005 I believe and in a little less than five years since it was made his researchers achieved their goal which started back in 1993.

Topics covered in the video, you can click on them just below the main display if you wish:

DNA and the Sea
Air Genome Project
Environmental Genomes
Engineered Species

The second http://www.ted.com/talks/craig_venter_is_on_the_verge_of_creating_synthetic_life.html"

This video was filmed in Feb 2008, and posted a month later in March.
FYI, an interesting side note, they put watermarks in the code, which basically means they can write poetry in the DNA base pairs if they wish.

http://www.jcvi.org/"

http://www.edge.org/3rd_culture/bios/venter.html"

excerpt:
DR. J. CRAIG VENTER is regarded as one of the leading scientists of the 21st century for his invaluable contributions in genomic research, most notably for the first sequencing and analysis of the human genome published in 2001 and the most recent and most complete sequencing of his diploid human genome in 2007.

He is Co-Founder, Chairman, CEO, Co-Chief Scientific Officer of Synthetic Genomics, Inc; as well as Founder, President and Chairman of the J. Craig Venter Institute. He was also the founder of Human Genome Sciences, Diversa Corporation and Celera Genomics. He and his teams have sequenced more than 300 organisms including human, fruit fly, mouse, rat, and dog as well as numerous microorganisms and plants.

Dr. Venter is also the key leader in the field of synthetic genomics. This work, trying to create the first synthetic genome, is leading to extraordinary advances in engineering microorganisms for many vital energy and environmental applications used at SGI. He is the author of more than 200 research articles and is among the most cited scientists in the world. He is the recipient of numerous honorary degrees and scientific awards including the 2008 National Medal of Science. He is also a member of many prestigious scientific organizations including the National Academy of Sciences.

He is the author of A Life Decoded: My Genome: My Life.

Rhody...
 
Last edited by a moderator:
This is research that I've been following for quite a while. It's interesting to take a historical perspective and look over the advancements that led to this achievement. Like most science, this research came along painfully slowly, and the researchers ran into many obstacles and dead ends.

The research has its beginning in a simple question, "what is the minimum genome that an organism needs to survive?" The research began in 1995 when Venter and colleagues sequenced the genome of Mycoplasma genitalium, whose 580,070 base pair genome is the smallest of any free-living organism. These scientists then began to tinker with the M. genitalium genome, inactivating different genes, and four years later in 1999 published a paper showing that only about 250-350 of the bacterium's genes were essential for survival. However, they obtained this result by inactivating genes one-by-one and seeing if the bugs still lived. One could argue that there might be synergistic effects between genes, so even if gene A and gene B are individually not required for survival, knocking both out at the same time could kill the organism. It seemed the only way to really rigorously determine the minimal genome required for an organism was to synthesize a minimum genome from scratch and see if it could survive.

In 2003, Venter founded an institute to tackle this enormous challenge and raised millions of dollars to do so. He brashly proclaimed that within 3 years, his institute could chemically synthesize a bacterial genome from scratch. In reality, it took five years and in 2008, Venter's institute published that they had synthesized the first synthetic bacterial genome, the 580,070 base pairs of M. genitalium. However, in the meantime, the institute had also developed a method for transplanting the genome of one bacterium into another bacterium, research that they published in 2007. Thus, in 2008, Venter's institute seemed to have all the pieces in place to create a bacterium with a synthetic genome.

Of course, in science, nothing is ever straightforward. Although the small size of M. genitalium was advantageous, the bacteria grew really slowly greatly hindering the speed of the research. Biting the bullet, they decided to switch to using the genome of the related bacterium M. mycoides, whose genome was nearly twice as large as that of M. genitalium, but the bacteria grew much faster. After they had finally synthesized and assembled the M. mycoides genome, they transplanted the genome into the host and... nothing happened. It turns out that they had made an error in a single base pair in a very important gene, a typo that took about 3 months to discover and correct.

Of course, all of these publications that I've mentioned have been landmark discoveries. Figuring out how to efficiently synthesize and assemble a synthetic bacterial genome was a landmark discovery. Showing that it was possible to transplant a bacterial genome into a host cell of a different species was a landmark discovery. Yet, these were two small steps toward this study, also a landmark paper in the field of synthetic biology. However, from a broader view, this paper is also just a small step toward synthetic life.

While the bacterium that Venter and colleagues created contains a synthetic genome, it was placed into an already functioning host. Furthermore, the host bacterium is closely related to the M. mycoides genome the authors used, so many of the hosts' biological processes were compatible with the synthetic genome, allowing the host's machinery to correctly read the synthetic genome. Eventually the host's machinery gets entirely replaced with components from the synthetic genome. However, it is still unclear whether this approach can work with genomes containing significant portions of DNA that are unrelated to the host genome and require different regulatory machinery to work. This point will be crucial if these synthetic bacteria are to be created for biotechnological applications. Therefore, the next big step in this field will be to show that any arbitrary genome can be "booted" into any arbitrary host. And, based on what Venter's institute has shown before, I have a feeling that they might actually get this to work too.

References:
Fraser et al. 1995. The Minimal Gene Complement of Mycoplasma genitalium. Science 270: 397-404. http://dx.doi.org/10.1126/science.270.5235.397

Hutchison et al.. 1999. Global Transposon Mutagenesis and a Minimal Mycoplasma Genome. Science 286: 2165 - 2169. http://dx.doi.org/10.1126/science.286.5447.2165

Gibson et al. 2008. Complete Chemical Synthesis, Assembly, and Cloning of a Mycoplasma genitalium Genome. Science 319: 1215 - 1220. http://dx.doi.org/10.1126/science.1151721

Lartigue et al. 2007. Genome Transplantation in Bacteria: Changing One Species to Another. Science 317: 632 - 638. http://dx.doi.org/10.1126/science.1144622
 
Ygggdrasil, I commend you for your excellently researched and eloquently written post. Thanks a lot!
 
Ygggdrasil said:
References:
Fraser et al. 1995. The Minimal Gene Complement of Mycoplasma genitalium. Science 270: 397-404. http://dx.doi.org/10.1126/science.270.5235.397

Hutchison et al.. 1999. Global Transposon Mutagenesis and a Minimal Mycoplasma Genome. Science 286: 2165 - 2169. http://dx.doi.org/10.1126/science.286.5447.2165

Gibson et al. 2008. Complete Chemical Synthesis, Assembly, and Cloning of a Mycoplasma genitalium Genome. Science 319: 1215 - 1220. http://dx.doi.org/10.1126/science.1151721

Lartigue et al. 2007. Genome Transplantation in Bacteria: Changing One Species to Another. Science 317: 632 - 638. http://dx.doi.org/10.1126/science.1144622

Nice job, Ygggdrasil

If you want full access to the articles and some partial content, you must subscribe http://www.sciencemag.org/subscriptions/indiv_register.dtl" access is free though.

The site is great, almost every area in science is covered with well written current science articles. I found one on something I have wanted to post on for some time.

Rhody...
 
Last edited by a moderator:
  • #10
  • #12
Andy Resnick said:
I heard about the report this morning- it's an amazing step forward.

But mycoplasma don't have mitochondria or ribosomes, do they? They don't have a cell wall... Are mycoplasma closer to a virus than a bacterium?

http://en.wikipedia.org/wiki/Mycoplasma

Because bacteria are prokaryotes, all bacteria, including mycoplasma, lack mitochondria (in fact, mitochondria are thought to derive from prokaryotes that were taken up by early eukaryotic cells). But, mycoplasma certainly contain ribosomes and their genes are closely related to those of other bacterial species. Perhaps the lack of a cell wall is one reason why Mycoplasma tend to have such compact genomes. Despite being relatively simple bacteria, mycoplasma are orders of magnitude more complex than viruses.

As an aside, scientists have been able to chemically synthesize some viruses from cell-free systems, a topic we recently discussed here (https://www.physicsforums.com/showthread.php?t=401033).
 
  • #13
I want to live forever. I hope geneticists can grant me this wish one day.
 
  • #14
Mu naught said:
I want to live forever. I hope geneticists can grant me this wish one day.

Mu naught,

If you were this guy, http://www.fantastic-voyage.net/" , you just might be able to afford it. He longs for the same thing. He has had genetic screening and is keenly aware of what genetic markers he has that may lead to disease. He aggressively treats himself with preventative measures for those conditions now, in hopes of prolonging his life long enough to be able to enjoy the fruits of gene research allowing him to live for a period well past a normal human lifespan. He has the money and access to the best experts in the field, giving him a better chance of prolonging his life more than most.

Rhody...
 
Last edited by a moderator:
  • #15
jim mcnamara said:
So when can we expect the Luddites/Frankenfood-ites in the US
The geographic origin of the term "Luddite" is Britain, and there is at least as much (probably way more) anti-GM public sentiment in the rest of the world as in the US.
 
  • #16
Ygggdrasil said:
Because bacteria are prokaryotes, all bacteria, including mycoplasma, lack mitochondria (in fact, mitochondria are thought to derive from prokaryotes that were taken up by early eukaryotic cells). But, mycoplasma certainly contain ribosomes and their genes are closely related to those of other bacterial species. Perhaps the lack of a cell wall is one reason why Mycoplasma tend to have such compact genomes. Despite being relatively simple bacteria, mycoplasma are orders of magnitude more complex than viruses.

As an aside, scientists have been able to chemically synthesize some viruses from cell-free systems, a topic we recently discussed here (https://www.physicsforums.com/showthread.php?t=401033).

+1 agree with everything said. In fact I believe that M.genitalium(SP?) has the smallest genome of any organism that isn't parasitic. It's still more complex than a virus though, but virus's are highly specialized cells.

I think the most important thing about mycoplasma having such small genomes is that it is easier to study them so we can gain knowledge about larger concepts in biology.

Ygggdrasil, also thanks for that extra research up above. :-p. I never knew that there were so many other people on these forums that like biology so much... I thought it was mostly engineers and mathematicians. :smile:
 
  • #17
Ygggrasil,

Dr Venter's company is on the cutting edge of Genomic research, that fact is without question. How will the results his team was able to achieve to be independently verified, or has it already been done ?

Rhody..
 
  • #18
I guess I am not as optimistic as Yggdrasil that Venter or anyone else will have such good luck with arbitrary genomic implants into arbitrary hosts, unless the genome's source and the host are quite closely biologically or phylogenetically related to begin with. Certainly one would not expect a prokaryotic genome to function in a eukarotic host or vice versa since the genetic regulatory machinery is so different, not to mention the cellular organization itself. I even doubt if a Mycoplasma-type genome implanted into a typical prokaryote like E. coli would work for the same general reasons. Eventually, such heterologous transplants might be made to work by engineering into the introduced genome all the necessary regulatory sequences required for expression by the particular type of host or recipient cell used, when these are already known. However, I still expect some really daunting problems even with homologous transplants as investigators try to move up the phylogenetic ladder to more complex cell types.
 
  • #19
rhody said:
Dr Venter's company is on the cutting edge of Genomic research, that fact is without question. How will the results his team was able to achieve to be independently verified, or has it already been done ?

Given the large amount of work involved and the great expense required to construct synthetic genomes, I don't really foresee many other groups using this technology, at least in the near future. However, as the price of gene synthesis goes down, other groups may attempt to use these techniques for other applications.

buddhakan said:
I guess I am not as optimistic as Yggdrasil that Venter or anyone else will have such good luck with arbitrary genomic implants into arbitrary hosts, unless the genome's source and the host are quite closely biologically or phylogenetically related to begin with. Certainly one would not expect a prokaryotic genome to function in a eukarotic host or vice versa since the genetic regulatory machinery is so different, not to mention the cellular organization itself. I even doubt if a Mycoplasma-type genome implanted into a typical prokaryote like E. coli would work for the same general reasons. Eventually, such heterologous transplants might be made to work by engineering into the introduced genome all the necessary regulatory sequences required for expression by the particular type of host or recipient cell used, when these are already known. However, I still expect some really daunting problems even with homologous transplants as investigators try to move up the phylogenetic ladder to more complex cell types.

You bring up some good points, and I agree with many. I also doubt that the mycoplasma genome would function if transplanted into E. coli. However, I think there might be ways to make this work. For example, from Shinya Yamanaka's work on induced pleuripotent stem cells, we know that injecting a set of 4 transcription factors is sufficient to reprogram any human cell into a stem cell. Maybe it's possible to find a small set of mycoplasma transcription factors that, when introduced into host with the genome, would reprogram the host to allow the mycoplasma genome to "boot up" correctly. Of course, this approach would not be so general because it would be dependent on the specific genome being used.
 
  • #20
There's a bit more detail in Venter's own press release, on the front of the TED site.

The work I'm more interested in is figuring out how these smallish genomes produce "life", that is, what is the individual task performed by (and physical mechanism employed by) each molecule that the genome codes for? Can anyone point me to where this sort of "reverse engineering" is done?
 
  • #21
Ran across this today in the news today, May 23 2010, from: http://www.guardian.co.uk/theobserver/2010/may/23/observer-profile-craig-venter"

Quite lengthy article that chronicles Venter's life: begins in 1968, in Vietnam during TET Offensive, interesting that he did not pursue his patent efforts after success in the Human Genome Project, but deferred to the requests of President Clinton, if he hadn't he would be one of the world's richest men by now:

excerpt:
He caused further outrage when he said he would not only beat that establishment club to the solution but patent the results. He eventually – arguably – made good the first part of that boast but, under pressure from President Clinton, gave up on the latter and agreed a joint declaration of the triumph with the official team in the millennium year, losing a fortune in the process. (Asked how he felt to have deciphered human life, Venter, who had designs on being "the first billionaire biochemist", replied: "Poorer.")
Since I am a physics admirer, I thought this observation by Freeman Dyson was interesting:
Freeman Dyson, the physicist, captured the full range of academic sentiment in this dry appraisal: "This experiment is clumsy, tedious, unoriginal. From the point of view of aesthetic and intellectual elegance, it is a bad experiment. But it is nevertheless a big discovery… the ability to design and create new forms of life marks a turning point in the history of our species and our planet."

and what others have said:
It's very easy to mock Venter," Jones suggests. "When he first appeared, people just kind of sneered at him. But they stopped sneering when they saw his brilliance in realising that the genome was not a problem of chemistry but a problem of computer power.

The last sentence above is particularly telling, a personal opinion that I share with Venter, not out of ego or wanting to be recognized, Ray Kurzweil and other noted leaders have stated for sometime that technologies ability to assemble large amounts of data is growing at an exponential rate, the Genome project, the four main experiments at the LHC and now research into this new area of Genomics cry out for a radical improvement in computing power, on the order of super exponential growth, tens of thousands of times faster then we have now, farms of distributed supercomputers sharing the load are simply inadequate to process what we have now. Not to mention the human coordination and communication required to create and maintain software required to do so. That is another technical and logistic nightmare in and of itself, not to mention actually processing the data from experiments.

As proof simply look how long it took the scientists an BNL to analyze and verify the collision data to finally announce discovery of Quark Gluon Plasma. I believe over two plus years. Not that the scientists were not being extremely careful in doing so, which may have accounted for some of the time. In any event, technological breakthroughs in this area are in demand, in the past some have risen to the challenge, and I have no doubt that it will happen again.

Rhody...
 
Last edited by a moderator:
  • #22
rhody said:
The last sentence above is particularly telling, a personal opinion that I share with Venter, not out of ego or wanting to be recognized, Ray Kurzweil and other noted leaders have stated for sometime that technologies ability to assemble large amounts of data is growing at an exponential rate, the Genome project, the four main experiments at the LHC and now research into this new area of Genomics cry out for a radical improvement in computing power, on the order of super exponential growth, tens of thousands of times faster then we have now, farms of distributed supercomputers sharing the load are simply inadequate to process what we have now.

Rhody, I completely agree with this assessment. When I first saw the headline, before even reading further or knowing about the process, my first thought was "computers can do that now?" I was also reminded of a statement Michio Kaku made on one of the more silly Science for Laymen TV shows on the Science Channel. I will paraphrase (I forgot the exact words):"The completion of the Human Genome project marks the start of a new era not of discovery but of mastery." In other words, using the information of genomes, which we already have, and building with them marks a new era in science. Much like the difference between the discovery of fire and finding creative ways of using it etc.
 
  • #23
ThomasEdison said:
Rhody, I completely agree with this assessment. When I first saw the headline, before even reading further or knowing about the process, my first thought was "computers can do that now?" I was also reminded of a statement Michio Kaku made on one of the more silly Science for Laymen TV shows on the Science Channel. I will paraphrase (I forgot the exact words):"The completion of the Human Genome project marks the start of a new era not of discovery but of mastery." In other words, using the information of genomes, which we already have, and building with them marks a new era in science. Much like the difference between the discovery of fire and finding creative ways of using it etc.

Thomas,

Thanks, this has been gnawing at my soul now for the past two or three years, tapping some of the greatest minds out there through the wonder of Google/uTube/articles/professional papers has driven this point home again and again. I was planning to start a "discovery thread on emerging technologies in increasing computing power", I invite you to beat me to it. I am juggling two or three things right now personally/professionally and don't have time to do it the justice it deserves. I promise to contribute though, every time I find an interesting link, I squirrel it away for future use, I have a few ready to go.

Rhody...
 
  • #24
rhody said:
Thomas,

Thanks, this has been gnawing at my soul now for the past two or three years, tapping some of the greatest minds out there through the wonder of Google/uTube/articles/professional papers has driven this point home again and again. I was planning to start a "discovery thread on emerging technologies in increasing computing power", I invite you to beat me to it. I am juggling two or three things right now personally/professionally and don't have time to do it the justice it deserves. I promise to contribute though, every time I find an interesting link, I squirrel it away for future use, I have a few ready to go.

Rhody...
Perhaps this is offtopic: Warning:

Go for it. I am probably too biased, too entirely pro-science and technology, to post a lot about these topics. I have been looking all over the internet for people's opinions relating to advances such as this one and I only see two camps of popular opinion. One camp is very luddite or religious/spiritual and the comments from it say that Scientists are always up to bad things and the same people love to make distinctions between what they regard as the "natural" order and what to them is "unatural." Not only do I disagree but I am not quick to make those distinctions anyhow.

I simply don't subscribe to the paranoia of "what are Scientists up to now?!?"
I also don't think that anything artificial must be bad and that anything natural must be good. The world is not that simple to me.

The other camp of popular opinion is more on the fence "Science is capable of great things, but in the wrong hands ... so we should be cautious" It is probably the most rational but I still don't agree. I would say this is a more nuetral stance.

So where are the pro-technology people? Where are the people cheering who say "Let's throw caution to the wind"? This may be an incorrect stance but that does not mean it should not be represented. From my position the balance of opinion about technology looks terribly skewed towards ludditism. I seem to be the only proponent (even if in an armchair fashion.)

I mentioned this article to several people I know and not one of them was excited or even thought it was a good thing.

Are there other people like myself who only see the good in advancement? Sometimes I feel like the only person with this viewpoint.
 
Last edited:
  • #25
does anyone know if there is an expository paper somewhere that covers gibson et al 2008?
 
  • #26
cesiumfrog said:
There's a bit more detail in Venter's own press release, on the front of the TED site.

The work I'm more interested in is figuring out how these smallish genomes produce "life", that is, what is the individual task performed by (and physical mechanism employed by) each molecule that the genome codes for? Can anyone point me to where this sort of "reverse engineering" is done?

You've just described the entire field of molecular biology. But, we know what many of the genes encoded by the genome do, and for some of the important ones, we have a very good mechanistic understanding of how they function. The really complicated part is figuring out how everything comes together. How are all of the functions of the cell coordinated? How do all of the interconnecting feedback mechanisms of a cell create a self-sustaining, homeostatic system? From a more mathematical point of view, we have a large system of coupled differential equations (representing chemical reactions, non-covalent bonding, etc.) and we want to determine what properties of this system create life. These questions are not likely to be answered soon, but hopefully research on synthetic life can help to frame some of these questions better and perhaps provide some insight.

ice109 said:
does anyone know if there is an expository paper somewhere that covers gibson et al 2008?

Here are some writeups from the popular press:
http://www.wired.com/science/discoveries/news/2008/01/synthetic_genome
http://www.nytimes.com/2008/01/24/health/24iht-24genome.9483638.html

And a short perspective on the paper by Biological Engineer Drew Endy (subscription required):
http://www.sciencemag.org/cgi/content/full/319/5867/1196
 
Last edited by a moderator:
  • #27
Thomas, and FYI to all,

Here is an older post link: https://www.physicsforums.com/showthread.php?t=364165" where I mention the subject of super exponential growth in processing the the end.
Cool TED video as well, highlights in the post, enjoy. Juan Enriquez is an engaging funny speaker...

Rhody... :cool:
 
Last edited by a moderator:
  • #28
How far are we away from synthesizing an entire organism instead of just the DNA? So, if we can do this, then we can make a right handed version of the DNA molecule and all the left handed molecules in the cell will then also be right handed.
 
  • #29
rhody said:
The last sentence above is particularly telling, a personal opinion that I share with Venter, not out of ego or wanting to be recognized, Ray Kurzweil and other noted leaders have stated for sometime that technologies ability to assemble large amounts of data is growing at an exponential rate, the Genome project, the four main experiments at the LHC and now research into this new area of Genomics cry out for a radical improvement in computing power, on the order of super exponential growth, tens of thousands of times faster then we have now, farms of distributed supercomputers sharing the load are simply inadequate to process what we have now. Not to mention the human coordination and communication required to create and maintain software required to do so. That is another technical and logistic nightmare in and of itself, not to mention actually processing the data from experiments.

I'm a little more jaded on this point. It's easy to generate PByte data sets- or datasets even larger. Unfortunately, our ability to extract information out of those datasets has not kept up with the rate we can generate data. Witness how 'genomics' has moved on to proteomics, metabolomics, immunomics, epigenetics, systems biology etc. etc. Each of those 'omics' can generate *far* more data than can be understood or digested. "science", especially in biology, is increasingly becoming the production of data that nobody ever looks at- including the teams that generated the data in the first place.
 
  • #30
Andy Resnick said:
Witness how 'genomics' has moved on to proteomics, metabolomics, immunomics, epigenetics, systems biology etc. etc. Each of those 'omics' can generate *far* more data than can be understood or digested. "science", especially in biology, is increasingly becoming the production of data that nobody ever looks at- including the teams that generated the data in the first place.

Andy,

Not working in the biological field, the mention of: proteomics, metabolomics, immunomics, epigenetics is news to me. Did these fields even exist, say 5 to 10 years ago ? I remember Juan Enriquez saying in my post #27 above, the TED Video (and this was a few years ago as well) that the average genome startup company creates more data in one month than exists in the Library of Congress.

If understood your point, you are saying that not only is computing power an issue, but intelligently designed software to analyze the results (as applied to the emerging fields of study listed above), correct ? What are the major software players that exist today ? Say the top five in analyzing genomic data. What new software is being considered ?

This has to do with LHC data, I saw a news clip recently where a person responsible for LHC experimental data showed the audience a room filled with Disk arrays each in its own enclosure, a total of 128 Units with each unit having 10 Petabytes (edit: possibly Petabits, not quite sure) of data of collected LHC experimental data, I presume as backup. A lot of data to say the least.

Finally, a question for ygggdrasil, are all of Venter's experimental data and methods open for peer review by other Genome Companies/NIST/DOE, etc.. ? and if not, why not ?

Rhody...
 
Last edited:
  • #31
rhody said:
Not working in the biological field, the mention of: proteomics, metabolomics, immunomics, epigenetics is news to me. Did these fields even exist, say 5 to 10 years ago ?

All of the "omics" fields really started taking off only in the late 1990s-2000s.

Finally, a question for ygggdrasil, are all of Venter's experimental data and methods open for peer review by other Genome Companies/NIST/DOE, etc.. ? and if not, why not

All of the experimental data and methods for the results the institute has published are available in their papers (in addition to the Science papers, the institute has some methods papers in other journals describing the methods in more detail). Also, the sequences used in all of the published projects are available in the Genbank sequence database (for example, the sequence of the synthetic DNA implanted into the cell in this most recent paper is available at http://www.ncbi.nlm.nih.gov/nuccore/296455217).
 
  • #32
Ygggdrasil said:
Here are some writeups from the popular press:
http://www.wired.com/science/discoveries/news/2008/01/synthetic_genome
http://www.nytimes.com/2008/01/24/health/24iht-24genome.9483638.html

And a short perspective on the paper by Biological Engineer Drew Endy (subscription required):
http://www.sciencemag.org/cgi/content/full/319/5867/1196

i was hoping for something that was actually expository. the popular write ups aren't detailed enough and gibsons paper assumes too much. the problem is that I'm not trained as a biologist and while i can look up the words and understand them i don't know why he's using the techniques that he is. for example i don't understand why he gets the cassettes synthesized then puts them into a BAC vector plasmid then cuts them out again with a type 2 restriction exonuclease.
 
Last edited by a moderator:
  • #33
Good article in the Wall Street Journal yesterday: http://online.wsj.com/article/SB10001424052748704026204575266460432676840.html?mod=googlenews_wsj"

Interesting approach, divide, overlap, reassemble at overlap points in three stages.

excerpts:
We started with the more than one million letters of genetic instructions for Mycoplasma mycoides, and then made slight modifications to its DNA sequence. First, we deleted 4,000 letters, which removed the function of two genes. We then replaced 10 genes with four "watermark" sequences. These watermark sequences are each over 1,000 letters in length and can be decoded to reveal the names of people, famous quotations and a website address. The entire sequence of DNA letters was then partitioned into 1,100 pieces, and each was synthesized using four different bottles of chemicals that make up DNA. These DNA fragments were designed such that adjacent pieces contained an 80-letter overlap, which facilitated the assembly process by providing unique regions where the synthetic pieces could join.

and
The synthetic Mycoplasma mycoides genome was assembled by adding the overlapping DNA fragments to yeast. Once inside a yeast cell, the yeast machinery recognized that two DNA fragments had the same sequence and assembled them at this overlapping region. The genome was not assembled from all 1,100 pieces at once but rather in three stages: 1,000 letters to 10,000 letters, 10,000 letters to 100,000 letters, and finally 100,000 letters to complete the 1.08 million letter genome. This assembled genome is the largest chemically defined structure ever synthesized in the laboratory.

Practical applications of this research:
We are currently working on the design of new cells that can much more efficiently capture carbon dioxide and "fix" (or incorporate) the carbon into new fuel molecules, new food oils, and new biologically derived sources of plastic and chemicals. We already have funding from the National Institutes of Health to use our synthetic DNA tools to build synthetic segments of every known flu virus so that we can rapidly build new vaccine candidates in less than 24 hours. We are also being funded to see if we can take sets of genes out of bacteria to design new synthetic pathways to make antibiotic compounds that are currently too complex for chemists to make.

Finally, a question for ygggdrasil, Andy Resnick,

It would seem that research (this question applies to the US) is well underway with work on "artificial life", a large number of Google hits confirm this. Do either of you know if said research is being done in the strictest of environments ?

I mean Biohazard Level IV (Doubly sealed, negative pressure buildings buried deep underground) Highly Secured Containment Facilities, and if so with oversight from official US agencies, NIST, DOE. One would hope so...

Rhody...
 
Last edited by a moderator:
  • #34
rhody said:
If understood your point, you are saying that not only is computing power an issue, but intelligently designed software to analyze the results (as applied to the emerging fields of study listed above), correct ? What are the major software players that exist today ? Say the top five in analyzing genomic data. What new software is being considered ?

I think that's about 1/2 right. Here's an interesting recent development:

http://www.livescience.com/technology/090402-robot-scientist.html

I'm not expert enough to say much more than that. I guess my claim is that the complete analysis of data requires insight and creativity, features currently not sufficiently developed in software.
 
  • #35
rhody said:
It would seem that research (this question applies to the US) is well underway with work on "artificial life", a large number of Google hits confirm this. Do either of you know if said research is being done in the strictest of environments ?

I mean Biohazard Level IV (Doubly sealed, negative pressure buildings buried deep underground) Highly Secured Containment Facilities, and if so with oversight from official US agencies, NIST, DOE. One would hope so...

Rhody...

I defer to ygggdrasil, but I do know that it is common to use Ebola and HIV virii bodies as carriers for DNA transfections, specifically because they are so infectious. One needn't get all "Andromeda Strain", either.

Plus there's research on the actual nasties themselves: ebola, anthrax, prions, etc., also not in highly secure labs.
 
  • #36
Andy Resnick said:
I defer to ygggdrasil, but I do know that it is common to use Ebola and HIV virii bodies as carriers for DNA transfections, specifically because they are so infectious. One needn't get all "Andromeda Strain", either.

Plus there's research on the actual nasties themselves: ebola, anthrax, prions, etc., also not in highly secure labs.

Indeed, however I'm pretty sure that they implement a 'kill-switch' into their organisms. There are many ways to make this work but I believe the 'popular' one is to make the organism somehow environment dependant. If it leaves the specific environment conditions of the lab, it will die. Or if it runs out of a specific energy source only really provided in the lab, it will die. They set them up with a 'suicide' gene to make this happen in the event that it does escape. I'm not sure how high-security is around the labs but I think they would be more worried about others getting into their data then about the organisms getting out and about.
 
  • #37
zomgwtf said:
Indeed, however I'm pretty sure that they implement a 'kill-switch' into their organisms. There are many ways to make this work but I believe the 'popular' one is to make the organism somehow environment dependant. If it leaves the specific environment conditions of the lab, it will die. Or if it runs out of a specific energy source only really provided in the lab, it will die. They set them up with a 'suicide' gene to make this happen in the event that it does escape. I'm not sure how high-security is around the labs but I think they would be more worried about others getting into their data then about the organisms getting out and about.

zomgwtf,

Wow, watermarking, kill-switches, environment survival factors... sounds like science fiction, I will take your word that it is science fact. This http://blogs.sciencemag.org/origins/2009/03/fast-mutating-viroids-hold-clu.html" gives me pause, however, something called: "Raw RNA".
While plant scientists try to figure out how to cure crops of viroids, other biologists are fascinated by them because they strip the processes of life down so far to the bone. Recently, Rafael Sanjuán of the University of Valencia in Spain and his colleagues decided to see how much viroids mutate. Humans, chrysanthemums, and other multicellular organisms have many ways of lowering their mutation rate. They can proofread their DNA as it is copied and correct errors. Bacteria are not quite so careful, but they can still repair a lot of DNA damage. Many viruses are decidedly sloppier. What's intriguing about this pattern is the size of the genomes involved: The higher the mutation rate, the smaller the genome.

Viroids offered a fresh opportunity to test this relationship, because they are hundreds of times smaller than viruses, the smallest genomes for which mutation rates had been estimated. Sanjuán and his colleagues infected chrysanthemums with viroids and then let them breed. The researchers then harvested the new viroids and scanned their genomes for mutations. In particular, they looked for mutations that would keep the viroids from replicating, because these must have been new. (They couldn't be carried down from earlier generations, because they keep the viroids from replicating.) To make sure these really were lethal mutations, the scientists engineered viroids with these mutations and injected the mutant viroids into plants. The plants didn't get sick.

and
If early RNA-based life forms had genomes on par with those of viroids, they would have had a gigantic mutation rate. We could not survive with such a high mutation rate because we have such a big genome, with so many vulnerable spots where mutations could deal lethal blows. With a much smaller genome, viruses can survive at a higher mutation rate. And viroids, smaller still, afford mutations an even smaller target.

But the reverse is also true: Without a way to lower their mutation rate, viroids are trapped below a so-called error threshold. The evolution of very accurate gene replication was thus probably a crucial stage in the emergence of more complex life. If life had stayed sloppy, we'd all still be little more than viroids.
The upside of this is that without a stable core of the genome as I understand it, life could not have evolved, a good thing. On the flip side, the fast mutation rate of small genomes is of concern, producing unpredictable results in a "mutated copy", even with all the safeguards built in as mentioned above.

Rhody...
 
Last edited by a moderator:
  • #38
Hey, sorry I didn't see your response before I had left or I probably could have responded back while you were still around :-p. Oh well.
rhody said:
zomgwtf,

Wow, watermarking, kill-switches, environment survival factors... sounds like science fiction, I will take your word that it is science fact.
I completely understand your skepticism to do with this. It does seem like a pretty far-fetched idea. So just to make sure you can see I'm not making things up I went looking for this specific technique being used by the Institute.

You can see here:
researchers will be able to engineer synthetic bacterial cells so they cannot live outside of the lab or other production environments. This is done by, for example, ensuring that these organisms have built in dependencies for certain nutrients without which they cannot survive. They can also be engineered with so called “suicide genes” that kick into prevent the organism from living outside of the lab or environment in which they were grown.
http://www.jcvi.org/cms/research/projects/first-self-replicating-synthetic-bacterial-cell/faq/#q8
That it discusses what I was talking about. I remembered reading about it that's why I posted it. So for when they create synthetic organisms they will be able to implement this feature.

The upside of this is that without a stable core of the genome as I understand it, life could not have evolved, a good thing. On the flip side, the fast mutation rate of small genomes is of concern, producing unpredictable results in a "mutated copy", even with all the safeguards built in as mentioned above.

Rhody...
Hmm. When I had first read your post and Andy's response I thought it was dealing with only genetically engineered bacterial organisms (I don't even know why I didn't read further into the part about viruses lol).
If it is only regarding genetically engineered organisms then yes: Viruses that are engineered can still be extremely dangerous, I believe even if their virulent genes are deleted or 'deactivated'. Exactly for the reason you posted, they can rapidly evolve especially when it comes to the ability to infect a greater amount of hosts. So if we engineer a virus specifically to target some other organism, I don't think there is any gurantee that it will not infect a nontarget host. I think this is what you're getting at correct?

Hmm... I can only assume that work done with a virus is done under strict biological confinement(which the above mentioned technique is a part of), and the virulent part of the DNA is deleted and deactivated and its generation time would be increased. I'm not so sure if this is related to the OP though because viruses and fungi are quite different from bacterial cells.
Here's a book from 2004 on the subject:
http://www.nap.edu/openbook.php?record_id=10880&page=169
(They also go into Suicide genes on page 173, if you're further interested in reading about it. But as I mentioned above it doesn't really work the same way on viruses)

I'll leave the rest of the answer for yggg, cause I'm not 100% sure of the safety concerns related to viruses on fungi at this institute :-p

Sorry for the confusion.
 
Last edited:
  • #39
ice109 said:
i was hoping for something that was actually expository. the popular write ups aren't detailed enough and gibsons paper assumes too much. the problem is that I'm not trained as a biologist and while i can look up the words and understand them i don't know why he's using the techniques that he is. for example i don't understand why he gets the cassettes synthesized then puts them into a BAC vector plasmid then cuts them out again with a type 2 restriction exonuclease.

Unfortunately, I don't think you'd be able to find an article like this. Your best bet would be to read up a molecular biology textbook to get an idea of how the general techniques work.

rhody said:
It would seem that research (this question applies to the US) is well underway with work on "artificial life", a large number of Google hits confirm this. Do either of you know if said research is being done in the strictest of environments ?

I mean Biohazard Level IV (Doubly sealed, negative pressure buildings buried deep underground) Highly Secured Containment Facilities, and if so with oversight from official US agencies, NIST, DOE. One would hope so...

Venter's work on the M. mycoides was not done in a BL4 lab and would not need to be done in any lab with anything more than the standard safety practices of a microbiology lab. The NIH publishes a set of guidelines for work on recombinant DNA (http://oba.od.nih.gov/rdna/nih_guidelines_oba.html ) that all biology labs follow. In addition, as zomgwtf mentioned, the bacteria we work with is non-pathogenic and has been bred/engineered to not be able to survive outside of the lab. Since Venter's synthetic bacterium is essentially the same as a normal M. mycoides, they pose no more risk to us or the environment as the mycoplasma species that ubiquitously inhabit our world.

The general field of synthetic biology, however, does pose some risks. For example, Venter has said that scientists could use his technology to create flu viruses for vaccine development. This work, and any work involving the synthesis of pathogens, would certainly have to be done in the appropriate facilities and follow existing guidelines for handling these agents. Synthetic biology could, in theory, allow people to obtain controlled pathogens (e.g. smallpox) for nefarious purposes. However, most gene synthesis companies screen customers' orders for sequences from known pathogens (http://www.genesynthesisconsortium.org/Gene_Synthesis_Consortium/Harmonized_Screening_Protocol.html) to help minimize this risk. In terms of what happens when the first completely new species is created using synthetic biology, I'm not sure what the safety requirements would be. Since Venter is interested in creating a bacterium with the smallest possible genome, it seems unlikely that this type of bacterium would pose a threat to anything as it would be unable to survive outside of very specific laboratory conditions.

Scientists have been modifying the genomes of bacteria and other species since the 1970s, when the first recombinant DNA technologies were being developed. Following some fairly common-sense guidelines (such as only working with potentially pathogenic species or sequences in controlled environments and using species that can only survive in laboratory conditions) has kept scientists and others safe from any unintended consequences of their work. The techniques developed by Venter and others certainly open up new possibilities in the realm of genome engineering, but Venter has pushed the bioethics of synthetic biology along with this work (for example, by recruiting bioethicists to review the field of synthetic biology and make suggestions both to his scientists as well as policy makers). I think that the existing regulatory frameworks that oversee research in biology as well as the standard safety practices used by biologists will be sufficient to deal with the potential dangers posed by synthetic biology.
 
Last edited by a moderator:
  • #40
As if you didn't need any new evidence on the sheer amount of data available on the internet, consider this: http://fastflip.googlelabs.com/view?q=view%3Apopular&a=0kbs3jlPJS8ieM&source=news&type=embed"

excerpt:
281 Exabytes of Online Data in 2009

In her presentation at PARC, intriguingly entitled 'The Physics of Data,' Marissa Mayer noted that there have been 3 big changes to Internet data in recent times:

1. Speed (real-time data);
2. Scale ("unprecedented processing power");
3. Sensors ("new kinds of data").

Mayer went on to say that there were 5 exabytes of data online in 2002, which had risen to 281 exabytes in 2009. That's a growth rate of 56x over 7 years. Partly, she said, this has been the result of people uploading more data. Mayer said that the average person uploads 15 times more data today (in 2009) than they did just 3 years ago.
and
Exascale Web

HP sees its role as providing the computing platform required to deal with this massive influx of data and the complexity of processing it in real-time. Google clearly sees itself as a provider of exascale web services.

We don't know yet which computing or Internet companies will be most successful over the next 5-10 years, but one thing is for sure. They'll have to know how to process and make sense of massive quantities of data flowing through the Web - and do it in real-time.

Rhody...
 
Last edited by a moderator:
  • #41
Hmm, maybe I'm pooping the party a bit.. But really, I haven't been able to see the huge scientific breakthrough here. Now I'm not a biochemist (even if I do some work on biochemical systems), but my girlfriend is, as are many of my friends and colleagues. And most of them seem to be of about the same opinion as me: Venter is very good at PR, and has been for quite some time, and that the amount of attention this got is somewhat disproportionate.

Sequencing DNA isn't new, nor is synthesizing a given sequence of DNA. Personally I don't really regard the genome as being 'chemically synthesized' from 'four bottles of chemicals' when they're in fact assembling the DNA using the same enzymes that do this in vivo. To me, synthesizing 'chemically' would be to use organic chemistry methods, not to use cells to do the job for you.

E.g. say you modify E. Coli or S. Cerevisae to express some protein for you, and purify it. (This is a routine task, almost doable by biochem undergrads these days) I've never heard such a protein being referred to as 'artificial', or 'chemically synthesized'. And if so - what meaning would these terms have?

Leaving some replication errors in (after finding by trial-and-error to that they were biologically insignificant), and then calling it a 'watermark' is a bit silly (but good PR). And then there's of course the whole question of whether replacing the genome of an pre-existing cell counts as "artificially synthesizing". I don't begrudge Venter his success, but I think it needs to be clear here that most of the work here was done using standard (commercialized, even) methods used all around the world every day.

It's certainly a milestone - but basically I'm saying it's an engineering milestone. They didn't do anything people hadn't done before, they just did it on a bigger scale. And made it sound like a lot more than it is.

It's akin to taking some prefabricated parts and assembling them into an engine, according to a given blueprint, and then mounting this engine into a pre-existing chassis/transmission/etc. You could say you built a car, but it'd be more correct to say you built an engine. And it would certainly be stretching it beyond credibility to say you built 'a car from scratch'.
 
  • #42
Andy Resnick said:
Plus there's research on the actual nasties themselves: ebola, anthrax, prions, etc., also not in highly secure labs.

Saywhat? Handling Ebola requires a BSL-4 facility (the highest level) and anthrax is BSL-3 (except for antibiotics-resistant anthracis which is BSL-4, too).

Prions aren't that dangerous to handle. I don't know why you'd worry about them.

(BTW, Rhody: AFAIK BSL-4 buildings aren't required to be underground. The ones I've seen haven't been.)
 
  • #43
You folks may enjoy the video of him announcing it:
http://goo.gl/6isZ

My ears are not those of a trained scientist - if you're in the same boat, jump to the last two minutes.
 
  • #44
alxm said:
Prions aren't that dangerous to handle. I don't know why you'd worry about them.

(BTW, Rhody: AFAIK BSL-4 buildings aren't required to be underground. The ones I've seen haven't been.)

alxm,

One quick off topic question: http://en.wikipedia.org/wiki/Prion" . I was under the impression that if you inhaled (through the nose) bone meal used for gardens, that just so happens to have prions in it from Mad Cow bones that in time you could develop CJD. I don't use bone meal to this day because of it. See text in blue from wiki link below.
A prion (pronounced /ˈpriː.ɒn/ ( listen)[1]) is an infectious agent that is composed primarily of protein.[2] To date, all such agents have been discovered to propagate by transmitting a mis-folded protein state; as with viruses the protein itself does not self-replicate, rather it induces existing polypeptides in the host organism to take on the rogue form.[3] The misfolded form of the prion protein has been implicated in a number of diseases in a variety of mammals, including bovine spongiform encephalopathy (BSE, also known as "mad cow disease") in cattle and Creutzfeldt–Jakob disease (CJD) in humans.

Rhody...
 
Last edited by a moderator:
  • #45
On Topic question for Andy, Yggg, zomgwtf, alxm,

With all of Venter's data/methods available for public scrutiny, will any other genetics Lab take on the task or reproducing their results ? Or would the feat simply take too long and cost too much money in order to do so ?

Rhody... :rolleyes:
 
Last edited:
  • #46
rhody said:
One quick off topic question: http://en.wikipedia.org/wiki/Prion" . I was under the impression that if you inhaled (through the nose) bone meal used for gardens, that just so happens to have prions in it from Mad Cow bones that in time you could develop CJD.

I'm no expert but it does sound plausible, if unlikely.
IF it had prions from mad-cow animals, if they're inhaled, if they can then get into your digestive tract, if they manage to survive your digestive tract without geting digested, if they then get into your blood, if they then get into your brain, if they can start 'replicating' there before being destroyed, and if your immune system can't stop the process. - It's got to be at least an order-of-magnitude or so less likely than getting CJD from eating a mad cow, which isn't terribly likely to begin with.

Personally I wouldn't worry, although you can always wear a paper respirator and bring that risk down yet another order of magnitude. Main point was, of course, not that prions are safe - but that there's a vast difference between 'safe to eat', 'safe to handle' and 'safe to handle in a lab'.

I'd rate purified prions as safe to handle in an ordinary chemical lab. They can't replicate on their own, they can't be absorbed through the skin, much less gloves, or inhaled as vapor (if they're in solution). They photo- and biodegrade, so they're not persistent, etc.

Now I went and looked it up, yes, purified prions are typically BSL-2, which is comparable to how hazardous chemicals are treated in a chem lab. Although I just realized this 'explanation' probably doesn't say much to everyone who doesn't have lab experience, but.. Basically I'm talking "be careful, use common sense, know what you're doing and what the risky actions are" level of safety and not "use extreme caution, think twice before every action" level.
 
Last edited by a moderator:
  • #47
JRDunassigned said:
My ears are not those of a trained scientist - if you're in the same boat, jump to the last two minutes.

Well, his ending there kind of illustrates my point - A good salesman.
It's all good and true. But he naturally leaves out the fact that these are things that very, very, many other people are working on (and that they're not neccesarily at the forefront of it). And that most of what he mentions (better vaccines, synthetic fuels, etc) are (at best) only tangentially related to the work he was announcing.
I'm prepared to give him the benefit of the doubt, but I can't really see any connection at all; i.e. why their 'synthetic' version of this bacteria be better for these purposes than the wild-type. Or indeed, why this species of bacteria would be useful at all. After all, they chose to reproduce this particular bacteria because it had a small genome (i.e. the least amount of work). There's no reason to assume it's the best choice for any other purpose.

rhody said:
With all of Venter's data/methods available for public scrutiny, will any other genetics Lab take on the task or reproducing their results? Or would the feat simply take too long and cost too much money in order to do so ?

Well, AFAIK (and I'm not in the field at all) Venter & Co were the only ones even attempting this to begin with. And again, I consider it more an engineering feat than a scientific one - a nice display of what can be done with current technology, but not something that pushed the boundaries of the technology itself much. So it sounds harsh but scientifically, I'm not sure there's much value in reproducing their result - because I'm not sure there's so much scientific value to begin with. I don't think anyone doubts they did it, and I don't think very many doubted it was possible with today's technology.

On the other hand it'll certainly be repeated eventually. But I think when they do, they'll have a specific reason for doing so. We've gone from 'we believe we can do it' to 'we know we can do it'. So now I think it's mostly a solution waiting for a problem. I know Venter has a project to try to pare down a bacteria to its bare minimum, to create a simple and well-understood organism. A 'vanilla' bacteria if you like. It might be that in that context, they'll want to re-synthesize the DNA 'from scratch' - in which case this is useful. If they're successful I think that'll end up having much more utility.
 
  • #48
Thanks to the OP (Gokul43201)for starting this topic.:biggrin: Mention of the article from Science was noted on Eurekalert. http://www.eurekalert.org/pub_releases/2010-05/aaft-su051710.php

Discussion about J. Craig Venter Ph.D. roused my interest. He seems to be involved with quite a few organizations and their projects. He is Chairman of Scientific Advisory Board, U.S. Genomics, Inc.
http://investing.businessweek.com/research/stocks/private/person.asp?personId=401200

U.S. Genomics, Inc. is a very interesting!

U.S. Genomics, Inc. Presents at 13th Annual Software Design for Medical Devices Conference, May-24-2010
04/26/2010
U.S. Genomics, Inc. Presents at 13th Annual Software Design for Medical Devices Conference, May-24-2010 . Venue: Westgate Hotel, San Diego, California, United States. Speakers: Paul Fernandes, Director, Software Development.

U.S. Genomics Inc. Signs Agreement with Becton, Dickinson and Company to Develop Infectious Disease Diagnostic Platform
09/23/2008
U.S. Genomics Inc. has entered into a strategic collaboration with Becton, Dickinson and Company to develop a novel infectious disease diagnostic platform. The collaboration would focus on application of U.S. Genomics' DirectLinear Analysis technology for the detection of infectious organisms in a single molecular diagnostic test.

U.S. Genomics Wins $9.1 Million Contract for Development of Advanced Biosensor by the U.S. Department of Homeland Security
07/16/2008
U.S. Genomics Inc. announced the award of a $9.1 million contract by the U.S. Department of Homeland Security (DHS) Science and Technology Directorate. The Phase IIIX contract under the Bioagent Autonomous Networked Detectors (BAND) program will enable U.S. Genomics to continue development, testing and optimization of the company's sophisticated biological sensor for the detection of airborne pathogens using single molecule DNA mapping technology. U.S. Genomics' unique DNA mapping technology allows extremely precise broadband detection of bacterial pathogens, toxins and viruses in a biological sample. The technology's readings are sensitive to the single-molecule level and yield extremely low false positive rates. Using a universal reagent set that can detect and identify pathogens, the technology produces a genetic signature unique to each DNA fragment in the sample, and also identifies the organism from which the DNA originates.
[Please read on . . .]
http://investing.businessweek.com/research/stocks/private/snapshot.asp?privcapId=96009
 
Last edited:
  • #49
alxm said:
It's akin to taking some prefabricated parts and assembling them into an engine, according to a given blueprint, and then mounting this engine into a pre-existing chassis/transmission/etc. You could say you built a car, but it'd be more correct to say you built an engine. And it would certainly be stretching it beyond credibility to say you built 'a car from scratch'.

But this paper is not the endpoint- going on with your analogy, once you've gotten experience building a kit car, the next step is to modify the kit.
 
  • #50
rhody said:
On Topic question for Andy, Yggg, zomgwtf, alxm,

With all of Venter's data/methods available for public scrutiny, will any other genetics Lab take on the task or reproducing their results ? Or would the feat simply take too long and cost too much money in order to do so ?

Rhody... :rolleyes:

From what I understand (and it's not much), the real value to others is publication of the 'recipe' (or 'technique', if you prefer). It's not obvious to me that anyone will try and duplicate the exact work, but I can guarantee there are other labs trying the same technique using their own cells right now.
 
Back
Top